Columbia Care Introduces Novel Oral Medical Cannabis Product to New York Market
Columbia Care Launches Nation’s First Dose-Metered, Extended-Release, Pharmaceutical-Quality Medical Marijuana Tablets
Patent-pending 10 milligram tablet will provide targeted and lasting relief across range of symptom and illness categories, including chronic pain
NEW YORK, March 8, 2018 /PRNewswire-USNewswire/ — Columbia Care LLC (“Columbia Care”), the nation’s leading medical marijuana company, announced today the introduction of proprietary, dose-metered, pharmaceutical-quality, hard-pressed tablets in New York State. This novel route of administration, the first of its kind available in the United States, is designed to provide long-lasting relief across a wide range of symptom and illness categories. The tablets are manufactured by segregating and formulating precise combinations of active compounds derived from targeted strains of medical marijuana plants. Columbia Care’s tablets will be available for registered patients the week of March 12.
The tablets’ unique formulations and drug delivery technology provide a discreet and targeted administration option for all patient groups, particularly those with fine motor control issues and patients managing the effects of chronic illnesses (such as epilepsy, neuropathy, PTSD and IBS/Crohn’s disease). The formulated tablets extend the release time of the active ingredients beyond that of oral and inhalable methods, aimed at reducing the required doses per day and patient costs while providing better long-term symptom control. Furthermore, in comparison to currently available liquid-filled capsules, tablets offer a longer duration of action without the risk of leakage or spoilage.
To fulfill Columbia Care’s mission of improving lives, we dedicate ourselves to leading through innovation. Developing and commercializing novel products and services is engrained in our DNA and is the foundation for the commitment we make to every person and community we serve. Today, patients and medical professionals now have one more treatment option that meets the consistency and quality they expect and deserve, while providing the lasting relief patients